Bank Of America Corp Virios Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.17 - $0.29 $12 - $20	72 Added 51.8%	211 $0
Q2 2024 Aug 14, 2024	BUY	$0.18 - $0.58 $25 - $80	139 New	139 $0
Q1 2022 May 16, 2022	SELL	$4.48 - $6.92 $35 - $55	-8 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$4.07 - $6.12 $32 - $48	8 New	8 $0

36.1K

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.